The design and development of a biosensor to measure the concentration of meconium in amniotic fluid.

Biomed Instrum Technol

Raytheon Systems Company, El Segundo, CA, USA.

Published: May 2001

Meconium aspiration syndrome occurs in 0.2% to 1% of all deliveries and has a mortality rate as high as 18%. The disease is responsible for 2% of all perinatal deaths. Meconium may be classified as being thick or thin, but this assessment is normally performed visually by clinicians. A "meconiumcrit" analysis has been developed to objectively define the concentration of meconium. However, this analysis does not provide real-time continuous readings. This study focused on the design and development of a sensor to provide an objective, continuous, real-time assessment of meconium thickness. Meconium has an absorption spectrum centered at 410 nm and observes Beer's law. Blue light centered at 430 nm was delivered through meconium solutions, and a photodiode translated the strength of the incoming light into a voltage. This voltage was analyzed by a microcontroller to determine the concentration of meconium.

Download full-text PDF

Source

Publication Analysis

Top Keywords

concentration meconium
12
design development
8
meconium
8
development biosensor
4
biosensor measure
4
measure concentration
4
meconium amniotic
4
amniotic fluid
4
fluid meconium
4
meconium aspiration
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!